Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
461studies shown
Showing 433-444 of 461
Drug study icon
Active Not RecruitingNCT06058039

Effects of Oral NMRA-335140 in people with Major Depressive Disorder

This study is active but not recruiting in the United States, in France, in Bulgaria, .... It is testing Effects of Oral NMRA-335140 for depression.

In France
DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Neumora Therapeutics, Inc.
Condition
Depression
Drug study icon
Active Not RecruitingNCT06029439

Safety and Effectiveness of NMRA-335140-501

This study is active but not recruiting in the United States, in France, in Canada, .... It focuses on Depression.

In France
DepressionDrugFrom 18 Years to 65 Years
Countries
United States, France, Canada, ...
Sponsor
Neumora Therapeutics, Inc.
Condition
Depression
Drug study icon
CompletedNCT01072630

Armodafinil Treatment for depression

This study is completed in the United States, in Australia, in France, .... It is testing armodafinil Treatment for depression.

In France
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression
Device study icon
CompletedNCT03217357

tDCS, Stress and Risk for Schizophrenia

This study is completed. It focuses on schizophrenia and currently lists study information in France.

In France
SchizophreniaDeviceFrom 18 Years to 30 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02150174

Testing Effect and Schizophrenia

This study is completed. It focuses on schizophrenia and currently lists study information in France.

In France
SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
France | Clinical Trials | HopeStage Research